Tune Therapeutics

Tune Therapeutics is a biotechnology company pioneering epigenetic therapies that modulate gene expression without altering DNA, using its proprietary TEMPO platform. The company develops treatments for complex, chronic, and age-related diseases, with a lead program targeting chronic hepatitis B. Tune is recognized as a leader in epigenome editing, advancing clinical-stage therapies and expanding the scope of genetic medicine.

Company Facts

• Headquarters: Durham, United States
• Founded: 2020
• Employees: 80
• Type: Private Company
• Website: https://tunetx.com
• Industries: Biotechnology, Genetic Medicine, Epigenetics, Life Sciences